Anticoagulation and venous thromboembolism in patients aged 90 years and older: Data from the RIETE registry

Background Age is a major risk factor for venous thromboembolism (VTE), yet patients aged ≥90 years are under‐represented in clinical trials of anticoagulant therapy. The objectives were to describe and compare patient clinical characteristics, treatments, and outcomes (VTE recurrence, bleeding, and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Geriatrics Society (JAGS) 2024-01, Vol.72 (1), p.113-125
Hauptverfasser:	Poenou, Géraldine, Nieto, José Antonio, Lumbierres, Marina, Bertoletti, Laurent, Adarraga, MD, Aibar, J, Alonso‐Carrillo, J, Alfonso, J, Amado, C, Arcelus, JI, Ballaz, A, Barba, R, Barbagelata, C, Barrón‐Andrés, B, Beddar‐Chaib, F, Botella, E, Castellanos, G, Chasco, L, Criado, J, Toro, J, De Juana‐Izquierdo, C, Díaz‐Brasero, AM, Espósito, F, Farfán‐Sedano, AI, Fernández‐Aracil, C, Fernández‐Reyes, JL, Fidalgo, MA, Angelina‐García, M, Gil‐De Gómez, M, Gil‐Díaz, A, Gómez‐Cuervo, C, Hernández‐Blasco, L, Jaras, MJ, Jiménez, D, Lainez‐Justo, S, Lecumberri, R, Lobo, JL, López‐De la Fuente, M, López‐Jiménez, L, López‐Miguel, P, López‐Sáez, JB, Maestre, A, Marchena, PJ, Marcos, M, Martín‐Martos, F, Martínez‐Redondo, I, Mercado, MI, Monreal, M, Muñoz‐Gamito, G, Navas, MS, Nieto, JA, Núñez‐Fernández, MJ, Olid, M, Otero, R, Pacheco‐Gómez, N, Pérez‐Ductor, C, Peris, ML, Pesce, ML, Poyo‐Molina, J, Puchades, R, Romero‐Brugera, M, Ruiz‐Giménez, N, Sendín, V, Torres, MI, Trujillo‐Santos, J, Valle, R, Vidal, G, Villalobos, A, Pabinger, I, Vanassche, T, Verhamme, P, Verstraete, A, Arguello, JD, Montenegro, AC, Hirmerova, J, Malý, R, Bura‐Riviere, A, Catella, J, Couturaud, F, Espitia, O, Grange, C, Le Mao, R, Mahé, I, Tzoran, I, Sadeghipour, P, Bilora, F, Ciammaichella, M, Dentali, F, Grandone, E, Negro, F, Pesavento, R, Taflaj, B, Tufano, A, Visonà, A, Vo Hong, N, Ozols, R, Meireles, J, Bounameaux, H, Caprini, JA, Weinberg, I
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged, 80 and over Anticoagulants - adverse effects Female Hemorrhage - chemically induced Hemorrhage - epidemiology Humans Life Sciences major bleeding Male Observational Studies as Topic patients aged 90 years or over Pulmonary Embolism - drug therapy Recurrence recurrent VTE Registries venous thromboembolism Venous Thromboembolism - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background Age is a major risk factor for venous thromboembolism (VTE), yet patients aged ≥90 years are under‐represented in clinical trials of anticoagulant therapy. The objectives were to describe and compare patient clinical characteristics, treatments, and outcomes (VTE recurrence, bleeding, and mortality) during the first 3 months of anticoagulation between VTE patients aged ≥90 years and those aged
ISSN:	0002-8614 1532-5415
DOI:	10.1111/jgs.18626